FAS and atherosclerosis: We envision that inhibiting glycolysis and FAS pathways in M1 macrophages, or enhancing FAO in M2 macrophages, may effectively reduce foam cell formation, mitigate inflammatory responses, and slow the progression of atherosclerosis.